![Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial - The Lancet Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2000996008/2003691070/gr1.gif)
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial - The Lancet
![PDF) Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial PDF) Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial](https://i1.rgstatic.net/publication/279726389_Acyclovir_Prophylaxis_Reduces_the_Incidence_of_Herpes_Zoster_Among_HIV-Infected_Individuals_Results_of_a_Randomized_Clinical_Trial/links/55f8126e08aeba1d9f025ebd/largepreview.png)
PDF) Acyclovir Prophylaxis Reduces the Incidence of Herpes Zoster Among HIV-Infected Individuals: Results of a Randomized Clinical Trial
![Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial - The Lancet Infectious Diseases Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/2005796654/2025321369/gr1.gif)
Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial - The Lancet Infectious Diseases
![Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial - The Lancet Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2001010456/2003789883/gr1.gif)